MidCap T ApS: Financial statements 2022
CVR: 40238581
MidCap T ApS (CVR 40238581) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,000 and a net result of DKK -11,000 compared with DKK -35,000 the year before. Equity amounted to DKK 119,310,000. The solvency ratio was 99.6%.
- Gross Profit
- -13,000 kr.
- Profit/Loss
- -11,000 kr.
- Equity
- 119,310,000 kr.
- Total Assets
- 119,760,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -13 t. | -11 t. | 119.3 mio. | - |
| 2021 | - | -19 t. | -35 t. | 119.3 mio. | - |
| 2020 | - | -158 t. | -32.2 mio. | 119.4 mio. | - |
| 2019 | - | -10 t. | -8 t. | 150.1 mio. | - |
Keep an eye on MidCap T ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MidCap T ApS has published its annual report for 2021. Gross profit came to DKK -19,000, and the net result was DKK -35,000.
About MidCap T ApS
MidCap T ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Martin Jørgensen. The company's owners include ORIFARM GENERICS HOLDING A/S, MBH ApS and Janus Investering ApS. In 2025, the company reported a gross profit of DKK -16,000 and a net result of DKK -24,871,000 compared with DKK 621,000 the year before. Equity amounted to DKK 173,650,000.
